Stay updated with breaking news from Rua Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rua Bioscience announced its official entry into the dynamic Australian medicinal cannabis market. Teaming up with Anspec, a leading pharmaceutical distribution company, Rua Bioscience product is now...
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/WPV6KSBFPBAGRMEEQ6X334VVYI.JPG)
The NZ sharemarket fell more than 4 per cent in August.
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/RZEAIYHQYREQFLDU6425S6ZYPE.JPG)
The index had a choppy trading session on the day National announced its tax plan.
Rua Bioscience ( NZSE:RUA ) Full Year 2023 Results Key Financial Results Net loss: NZ$5.96m (loss narrowed by 31% from...
Results in line with expectations and achieves first international sales. Summary financials FY23 $ FY22 $ Revenue (from customers) 357,675 24,226 Revenue (incl. fair value gains) 6,532,612 646,098 Profit/(Loss) before tax (5,958,506) (7,485,985) ...